Keratinocyte migration is an early event in the wound healing process. Although we previously found that CD9 downregulation is required for the keratinocyte migration during wound repair, the mechanism of how CD9 expression is regulated remains unclear. Here, we observed the effect of hypoxia (2% O 2 ) on CD9 expression and keratinocyte migration. CD9 expression was downregulated and keratinocyte migration was increased under hypoxic conditions. In addition, CD9 overexpression reversed hypoxia-induced cell migration. We also found that hypoxia activated the p38/MAPK pathway. SB203580, a p38/MAPK inhibitor, increased CD9 expression and inhibited keratinocyte migration under hypoxia, while MKK6 (Glu) overexpression decreased CD9 expression and promoted hypoxic keratinocyte migration. Our results demonstrate that hypoxia regulates CD9 expression and CD9-mediated keratinocyte migration via the p38/ MAPK pathway. C D9, a member of the tetraspanin superfamily, has been implicated in a variety of cellular and physiological processes, including cell motility 1, 2 , migration and adhesion [3] [4] [5] [6] . Our previous study revealed that CD9 is involved in wound re-epithelialization and that CD9 expression in the migrating epidermis is downregulated following wounding and then increases, reaching levels comparable to that observed in normal skin epidermis when re-epithelialization is complete 7 . Our in vitro results also showed that CD9 downregulation promotes keratinocyte migration 8 . These results indicate that low levels of CD9 are required for re-epithelialization, but little is known about how CD9 expression is regulated during wound healing.
C D9, a member of the tetraspanin superfamily, has been implicated in a variety of cellular and physiological processes, including cell motility 1, 2 , migration and adhesion [3] [4] [5] [6] . Our previous study revealed that CD9 is involved in wound re-epithelialization and that CD9 expression in the migrating epidermis is downregulated following wounding and then increases, reaching levels comparable to that observed in normal skin epidermis when re-epithelialization is complete 7 . Our in vitro results also showed that CD9 downregulation promotes keratinocyte migration 8 . These results indicate that low levels of CD9 are required for re-epithelialization, but little is known about how CD9 expression is regulated during wound healing.
Wound healing is a dynamic and well-ordered biological process, in which re-epithelialization plays an early important role 9, 10 . Re-epithelialization of skin wounds depends upon keratinocytes migration from the wound margins and is enhanced when keratinocytes are covered with occlusive dressings that induce hypoxia 11 . After acute tissue injury, the wound microenvironment is virtually devoid of oxygen, which results from the vascular disruption caused by the injury, the high oxygen consumption caused by high cell density and cell activity in granulation tissue 12, 13 . Increasing amounts of research have revealed that hypoxia plays a role as an early stimulus for initiation of re-epithelialization and tissue repair/angiogenesis [14] [15] [16] . In addition, hypoxia is localized to the leading edge of the healing epidermis area starting from day 2 after wounding and peaking at day 3 after wounding; the oxygen tension in the wound tissue at the day 3 is less than 10 mmHg 17, 18 . The temporal appearance of hypoxia correlates well with the downregulation of CD9 expression during wound repair. Hypoxia also promotes keratinocyte motility over connective tissue components and enhances keratinocyte migration 11, 19, 20 . In addition, hypoxia regulates tetraspanin expression in cancer cells, which plays an important role in cell migration [21] [22] [23] . Thus, we hypothesize that hypoxia regulates CD9 expression and CD9-mediated keratinocyte migration during wound healing.
In mammalian cells, responses to hypoxia at the molecular transduction level are hallmarks of adaptation and survival under oxygen deprivation conditions. An increasing number of studies have demonstrated that mitogen activated protein kinase (MAPK) systems, especially p38/MAPK, are activated under hypoxia [24] [25] [26] . Additionally, wounding activates p38/MAPK in leading keratinocytes 27 and the p38/MAPK pathway is required for keratinocyte migration 28, 29 . Inhibition of p38/MAPK impairs the formation of keratinocyte outgrowths in human skin organ cultures, as well as the migration of keratinocytes in an in vitro wound assay 30 . Accordingly, these data prompted us to investigate the function of p38/MAPK in the regulation of CD9-mediated keratinocyte migration under hypoxia.
In the present study, we used HaCaT cells and primary mouse keratinocytes (MKs) to identify a role for hypoxia in regulation of CD9 expression and keratinocyte migration. We found that CD9 expression is downregulated in hypoxic keratinocytes and CD9 overexpression is sufficient to reverse the hypoxia-induced keratinocyte migration, while CD9 silencing accelerates hypoxic keratinocyte migration. The p38/MAPK pathway plays an important role in regulating CD9 expression and keratinocyte migration under hypoxia. Collectively, our findings suggest that in both HaCaT cells and MKs, the hypoxia-activated p38/MAPK pathway participates in regulation of CD9 expression and cell migration. These results provide novel insights into mechanisms of tetraspanin CD9 regulation and keratinocyte migration during wound healing.
Results
Hypoxia decreases CD9 expression in keratinocytes. To observe the changes in CD9 expression under hypoxia, HaCaT cells and MKs were subjected to hypoxia for 12 hours, 24 hours and 36 hours. We then analysed CD9 protein levels using western blot. The CD9 protein level in both HaCaT cells and MKs significantly decreased after 12 hours of hypoxia treatment, compared with normoxic keratinocytes (Fig. 1A and Supplementary Fig. S1A ). Moreover, real-time PCR analysis also revealed that CD9 mRNA levels were significantly reduced in hypoxic keratinocytes (Fig. 1B) . These results indicated that CD9 expression in keratinocytes was downregulated under hypoxic conditions.
Effect of CD9 on hypoxia-induced keratinocyte migration. Many reports have revealed that hypoxia promotes keratinocyte migration 19, 20 . Since we previously found that CD9 downregulation also contributes to keratinocyte migration during wound hearing 8 , we hypothesized that CD9 could account for regulation of keratinocyte migration under hypoxia. Recombinant adenovirus vectors for overexpressing CD9 (Ad-CD9) and silencing CD9 (siCD9) were constructed and used to infect HaCaT cells prior to hypoxia treatment. The effects of adenovirus infection were quantified and verified before further experiments. After infection for 48 hours, more than 90% of the keratinocytes confirmed to be infected by observing GFP expression using a fluorescent microscope (Supplementary Fig. S2A and S2B ). The effective silencing of endogenous CD9 or overexpression of CD9-GFP fusion proteins was confirmed using western blot ( Supplementary Fig. S2C ) and fluorescenceactivated cell sorting (FACS) analysis (Supplementary Fig. S2D ). We then evaluated the effect of CD9 on hypoxic HaCaT keratinocyte migration using the scratch wound assay. Our results showed that hypoxia induced HaCaT cell migration compared with normoxic cells and CD9-overexpression reversed the hypoxiainduced cell migration, while CD9 silencing increased cell migration. After 20 hours, hypoxic keratinocytes migrated into over 75% of the scratched area (H1Mock group and H1Vector group), while normoxic keratinocytes occupied only 54%. In addition, keratinocytes with CD9 overexpression migrated into only 39% of the area (Ad-CD9 group) under hypoxia, while CD9-silenced keratinocytes were present in over 95% of the scratched area (siCD9 group), compared with over 75% for the scramble-infected keratinocytes (H1Mock group and H1Vector group) (Movie 1, Fig. 2A and 2B). No difference in cell proliferation was detected in these groups ( Supplementary Fig. S3A ). Thus, cell proliferation can be excluded as a possible explanation for changes in migratory capacity of CD9-regulated keratinocytes under hypoxia. The regulatory role of CD9 in hypoxia-induced keratinocyte migration was further confirmed using the transwell migration assay in both HaCaT cells and MKs. The number of cells migrating through the porous membranes of the transwell chambers was increased by 64.7% in CD9-silenced HaCaT cells and 44.8% in CD9-silenced MKs, but decreased by 47.5% in CD9-overexpressed HaCaT cells and 51.3% in CD9-overexpressed MKs, compared with the scramble-infected keratinocytes (H1Mock group and H1Vector group) (Fig. 2C ). Taken together, these results demonstrate that CD9 plays an important role in hypoxia-induced keratinocyte migration.
Hypoxia activates p38/MAPK signaling pathway. To further elucidate the signaling events involved in the hypoxia-induced effects on CD9 expression and cell migration, we investigated the status of p38/ MAPK in hypoxic HaCaT cells and MKs. Phosphorylated p38 (pp38) and p38 were tested using immunoblotting (Fig. 3) . Hypoxiainduced phosphorylation of p38/MAPK was significantly elevated by hypoxia for 12 hours with a 1.6-fold increase in HaCaT cells and 1.7-fold increase in MKs and remained elevated throughout the 36 hours of hypoxia, compared with normoxic keratinocytes. We also observed that the p38/MAPK pathway was markedly activated in the newly formed migrating epidermis post-wounding, where keratinocytes were under hypoxia conditions (Day 5, Supplementary  Fig. S5 ).
Effect of p38/MAPK pathway on hypoxia-induced changes in CD9 expression. To test whether hypoxia-induced changes in CD9 expression depend on the p38/MAPK activity, we treated HaCaT cells and MKs with the p38/MAPK inhibitor, SB203580. SB203580 treatment resulted in a significant increase in CD9 protein www.nature.com/scientificreports expression under hypoxic conditions (2% O 2 for 24 hours), while there was no change under normoxic conditions ( Fig. 4A and Supplementary Fig. S1B ). We then further overexpressed the p38 kinase activator MKK6 (Glu) in these cells. MKK6 is known to phosphorylate p38/MAPK on Thr-180 and Tyr-182, which leads to p38/MAPK activation 31 . The cells were transfected with MKK6 (Glu) recombinant adenoviruses. After infection for 48 hours, more than 90% of the HaCaT cells and MKs were determined to be infected by observing GFP expression using a fluorescent microscope (Fig. 4B) . The effective activation of p38/MAPK was confirmed using western blot (data not shown). The effects of overexpressing MKK6 (Glu) on CD9 expression are shown in Fig. 4C and  supplementary Fig. S1C . MKK6 (Glu) overexpression resulted in a reduction in the CD9 protein levels by 3.25-fold in HaCaT cells and 6.8-fold in MKs. These results suggest that the p38/MAPK pathway is involved in regulating CD9 expression.
Involvement of the p38/MAPK pathway in hypoxia-induced keratinocyte migration. To study the p38/MAPK signaling mechanism involved in regulating hypoxia-induced keratinocyte migration, we assessed hypoxic keratinocyte migration with or without the p38/MAPK inhibitor, SB203580 and the MKK6 (Glu) recombinant adenovirus, using the cell scratch wound assay and the cell migration assay. Under hypoxic conditions (2% O 2 ), SB203580 treatment significantly impaired HaCaT cell migration, while MKK6 (Glu) overexpression significantly increased the cell migration (Movie 2). After 20 hours, wound closure was reduced 1.5-fold in hypoxic HaCaT cells after addition of SB203580, while it was increased 1.6-fold in MKK6-infected cells (Fig. 5A and 5B). No difference in cell proliferation was also detected in these groups ( Supplementary Fig. S3B) . Moreover, the cell migration assay also showed that p38/MAPK inhibition significantly suppressed HaCaT cell migration (1.6-fold reduction) and MKs (1.5-fold reduction) under hypoxia, and p38/MAPK activation promoted HaCaT cell migration (2.1-fold increase) and MKs (1.9-fold increase) ( Figure 5C and 5D). Our findings suggest that the p38/MAPK pathway participates in hypoxia-induced keratinocyte migration.
Discussion
Wound healing is a complex process requiring coagulation, reepithelialization, angiogenesis, fibroplasia, contraction, and remodeling 9, 32 . Keratinocyte migration is an early event in the process of re-epithelialization 33 . Our previous study revealed that downregulation of CD9 is critical to initiate keratinocyte migration during wound healing 7, 8 . The change in CD9 expression is also implicated in the migration of other cells 4, 6, 34 . However, the mechanism that regulates CD9 expression remains unknown. In the current study, we demonstrated that hypoxia downregulates CD9 expression and promote keratinocyte migration via the p38/MAPK pathway.
It has been thought that wounds begin when physical damage to a tissue causes a disruption in oxygen supply, leading to a drop in oxygen tension in the wound tissue 35, 36 . Following injury, vascular damage results in the loss of perfusion and low oxygen tension (hyp- oxia). This may be exacerbated by a rapid influx of inflammatory and mesenchymal cells with high metabolic demands for oxygen 37 . Hypoxia can be detected on re-epithelializing sheets during cutaneous wound healing in the early proliferative phase using pimonidazole adduct staining, and the oxygen tension is less than 10 mmHg 38, 39 . Hypoxic stress after acute injury activates genes and growth factor synthesis, leading to tissue repair/angiogenesis 14 . In addition, the use of semi-occlusive dressings in cutaneous wound healing promotes re-epithelialization and wound closure compared with wounds that are allowed to air-dry, but the dressings must be used early after wounding to induce rapid re-epithelialization in vivo [40] [41] [42] [43] . Wounds allowed to air-dry have oxygen tensions between 1-4% at the surface where keratinocytes are migrating 17, 44 . Our previous results showed that CD9 was downregulated after wound injury, followed by an increase to a normal level in normal skin epidermis when re-epithelialization is fully completed 7 , which correlates well with the appearance of hypoxia. In the present study, we found that hypoxia (2% O 2 ) downregulated CD9 expression (Fig. 1) and induced keratinocyte migration, while CD9 overexpression reversed promoting effect of hypoxia on migration (Fig. 2) . This indicates that hypoxia regulates CD9 expression in keratinocytes and CD9 is also involved in hypoxia-induced cell migration.
CD9 is a member of the tetraspanins family. The most peculiar feature of tetraspanins is their ability to associate with other tetraspanins, integrins and signaling receptors, thereby forming tetraspanin-enriched microdomains on the cell surface 45 . The accumulation of CD9, CD81, and CD151 has been found to locate in normal human keratinocytes and be involved in cell migration 46 . The best characterized interactions of tetraspanins are those with integrins, which are involved in signaling pathway 47 . CD9 forms a complex with integrin a6, a3, b1, b4 in keratinocytes, which plays an important role in cell migration 48, 49 . Thus, CD9 may participate in keratinocyte migration through regulating the interaction with other molecules. Further work is required to elucidate the possible interaction of CD9 with other molecules in hypoxia-induced cell migration. In addition, our previously results showed that CD9 downregulation in keratinocytes contributes to cell migration via upregulation of matrix metalloproteinase-9 (MMP-9) 8 . MMP-9 degrades the extracellular matrix and is required for tubular network formation 50 and the actin cytoskeletal organization 51 , which are essential for cell migration. O'Toole et al. revealed that hypoxia promotes keratinocyte migration and that hypoxia-induced MMP-9 secretion plays an important role in the process 11, 20 . All these results suggest that CD9 plays a key role in keratinocyte migration.
CD9 has been implicated in cell migration and cancer invasion and metastasis 34, 52, 53 . Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma 54 and peritoneal dissemination of human ovarian carcinoma cells 55 . We previously found that CD9 downregulation is critical for initiating keratinocyte migration during wound healing 7, 8 . In this study, we revealed that hypoxia is a key point that regulates CD9 expression. Carcinoma cells are also in a hypoxic microenvironment 56, 57 , and down-regulation of CD9 expression during prostate carcinoma progression is associated with a change in CD9 expression 58 . These results indicate that hypoxia may regulate the CD9 expression level in carcinoma cells.
Interestingly, we found that hypoxia activates the p38/MAPK pathway, which is negatively related to CD9 levels in hypoxic HaCaT cells and MKs (Fig. 3) . Additionally, accumulating data indicates that the p38/MAPK pathway is involved in the intracellular signaling events triggered by hypoxia. Thus, we pharmacologically inhibited p38/MAPK using SB203580 and overexpressed an endogenous p38/MAPK activator, MKK6, to observe the changes in CD9 levels in hypoxic HaCaT cells and MKs. We found that inhibition of p38/MAPK signaling increased CD9 expression in hypoxic keratinocytes, while p38/MAPK activation decreased it. These findings suggest that the p38/MAPK pathway is involved in the process of CD9 changes induced by hypoxia. It has been reported that the p38/ MAPK pathway is activated under hypoxia 26, 59 , and we found that hypoxia-activated p38/MAPK activation regulated CD9 expression, but the mechanism of how the p38/MAPK interacts with CD9 is not clear. Future studies are expected to reveal the details of this process.
In addition, our results also demonstrated that activation of p38/ MAPK signaling accelerates keratinocyte migration under hypoxia, while inhibition of p38/MAPK results in slower cell migration (Fig 5) . Activation of the p38/MAPK pathway was also implicated in promoting keratinocyte migration 28, 60, 61 , but there is no research showing that hypoxia-activated p38/MAPK signaling is involved in the keratinocyte migration. Moreover, it has been reported that wounding activates the p38/MAPK pathway which activates transcription factors in the leading keratinocytes 27 , and p38/MAPK pathway regulates cellular migration in epithelial wound healing 29 . Thus, during the early stage of wound repair, the hypoxic conditions around the wound tissue may induce keratinocyte migration through the activation of the p38/MAPK. Taken together, we observed that hypoxia downregulates CD9 by activating the p38/MAPK pathway, which promotes keratinocyte migration in both hypoxic HaCaT cells and MKs. These findings provide new insights into the molecular mechanism of CD9 protein changes in keratinocytes that initiate cell migration during wound healing. Cell culture and hypoxia treatment. HaCaT cells were obtained from Cell Bank of the Chinese Academy of Sciences in Beijing, China. Cells were cultured in RPMI 1640 medium (Hyclone, USA) supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, and 10% fetal bovine serum (Hyclone, USA). The cells were incubated at 37uC, 5% CO 2 , and 95% humidity. MKs were cultured using a modification of a described method 62 . Briefly, MKs were isolated from skin of newborn BALB/c mice (postnatal day 1-3) by 0.25% trypsin/0.04% EDTA solution (Invitrogen, USA) at 4uC overnight, and primary cultures were established in keritinocyte serum-free medium (K-SFM medium) (Gibco, USA). The second-passage mouse keratinocytes were plated with the K-SFM medium and used in the subsequent experiments. The cells were incubated at 37uC, 5% CO 2 , and 95% humidity.
Methods
Hypoxic conditions of 2% O 2 , 5% CO 2 and 93% N 2 were created by a continuous flow of nitrogen by using a Forma Series II Water Jacket CO 2 incubator (model: 3131; Thermo Scientific). The p38/MAPK inhibitor, SB203580 (Beyotime) (5 mmol/L), was added to these cultures and allowed to incubated at 37uC for 30 minutes before hypoxia treatment.
Western blot analysis. Cells were washed with ice-cold phosphate-buffered saline (PBS), harvested in 70-200 mL of 13 loading buffer on ice, and homogenized. Lysates were sonicated for 4 seconds, and separated by centrifugation at 4uC and 14000 g for 2 minutes. Protein concentration was determined by RCDC protein assay kit (Sigma, USA). The lysates containing 10 or 20 mg of proteins were separated on 10% SDS-PAGE gel, and transferred electrophoretically to polyvinylidene difluoride (PVDF) membranes. All the following antibodies were used at 151000 dilution, the loading control anti-GAPDH at 155000 dilution, and the secondary antibody at 154000 dilution. The blots were probed using primary antibodies: anti-CD9 (Millipore, USA), anti-p38, anti-phospho-p38 at Thr180/Tyr182 (Cell Signaling, USA). Horseradish peroxidase-conjugated IgG was used as a secondary antibody and GAPDH was used as loading control. The results were analysed with ChemiDoc imaging system (Bio-Rad, USA).
Real-time PCR of CD9 mRNA. Total RNA was extracted from HaCaT cells and MKs with TRIzol reagent (Invitrogen, USA) according to the manufacturer's instructions. CD9 mRNA was subjected to RT-PCR with a Realtime 7500 PCR apparatus (Applied Biosystems) according to the instruction manual (SYBRII Green Realtime PCR; Toyobo). The results were analysed with Applied Biosystems 7500 system v1.4.0 software. The sense and antisense primers for human CD9 and GAPDH were as follows: CD9 (59-CCTGCTGTTCGGATTTAACTTCA-39; 59-TGGTCTGA GAGTCGAATCGGA-39) and GAPDH (59-GGTGGTCTCCTCTGACTTCAACA-39; 59-GTTGCTGTAGCCA AATTCGTTGT-39). PCR conditions were: denaturing once at 95uC (5 minutes), then 40 cycles at 95uC (30 seconds), 62uC (1 minutes) and 72uC (1 minutes).
Recombinant adenovirus vector for overexpressing or silencing of CD9 expression. The recombinant adenovirus vectors for overexpressing CD9 (Ad-CD9), the negative control adenovirus vector (Vector) or for silencing of CD9 expression (siCD9) and the negative vector containing non-specific shRNA (Mock) were purchased from Shanghai GeneChem, Co. Ltd (Shanghai, China). All vectors contained the gene for green fluorescent protein (GFP), which served as a marker. HaCaT cells and MKs were infected with these vectors at a multiplicity of infection of 10 for 48 hours, and these cells were used in the experiments.
MKK6(Glu) recombinant adenovirus construction and transduction. The recombinant adenovirus vectors Ad-MKK6(Glu)-GFP and the negative vector EGFP (GFP) were produced by Shanghai GeneChem, Co. Ltd (Shanghai, China). The transgene expression in HaCaT cells and MKs was observed under a fluorescence microscope (Leica Micro systems, Germany) to determine the infection efficiency by visualizing GFP expression.
Cell scratch wounding assay and time-lapse videomicroscopy. Scratch wounding assay was performed as described previously 8 . HaCaT cells uninfected or infected with recombinant adenoviruses were grown to confluence in the 24-well plates in serum conditioned RPMI 1640. Scratch wounds were created in confluent monolayers using a sterile p20 pipette tip and different fields were filmed for 20 hours under normoxic or hypoxic conditions using a Zeiss videomicroscope then analysed using the NIH ImageJ image software (http://rsb.info.nih.gov/ij/).
In vitro cell migration assays. Cell-migration assays were performed using polycarbonate filters (8 mm pore size, Transwell; Becton Dickinson, USA). The lower chamber was filled with 600 mL of RPMI 1640 medium supplemented with 10% FBS, and the cells were plated at a density of 3 3 10 5 in 100 mL of migration buffer in the upper chamber of triplicate wells followed incubation at 37uC for 20 hours. Transwell inserts were then fixed with 10% formalin, stained using 0.5% crystal violet in 10% ethanol for 10 minutes and washed with PBS three times. Cells in the upper compartment were removed using a cotton wool swab, and the filter was mounted onto glass slides. Cells from 5 random fields were counted under 1003 magnification. Mean cell numbers for each sample were from triplicate inserts.
Statistical analysis. Data are expressed as mean 6 standard deviation (SD). SPSS 13.0 was used for statistical analysis and significance was evaluated by one-way ANOVA. P values , 0.05 were considered statistically significant.
